AAAAI: Omalizumab as effective as multifood oral immunotherapy for individuals with food allergy
Medical Xpress
March 7, 2026
Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.
Verticals
healthmedical
Originally published on Medical Xpress on 3/7/2026